Cite
HARVARD Citation
Cheah, C. et al. (2016). Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high‐risk follicular lymphoma due to severe haematological and infectious toxicity. British journal of haematology. pp. 531-533. [Online].